Evidence map›Paper›PMID 24752297›Full record

ArticleThe Journal of experimental medicine2014

Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function.

Lalit Kumar, Janet Chou, Christina S K Yee, Arturo Borzutzky, Elisabeth H Vollmann, Ulrich H von Andrian, Shin-Young Park, Georg Hollander, John P Manis, P Luigi Poliani and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Mechanosensing in Metabolism.Comprehensive Physiology · 2023
    Review
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Lalit KumarDivision of Immunology and 2 Joint Program in Transfusion Medicine, Division of Laboratory Medicine, Boston Children's Hospital; and 3 Department of Pediatrics, 4 Department of Microbiology and Immunobiology, and 5 Department of Pathology, Harvard Medical School, Boston, MA 02115.
Janet Chou
Christina S K Yee
Arturo Borzutzky
Elisabeth H Vollmann
Ulrich H von Andrian
Shin-Young Park
Georg Hollander
John P Manis
P Luigi Poliani
Raif S Geha
Pediatrics and Genetics · USBoston Children's Hospital · USChildren's Hospital 1 · VNHarvard University · USMRC Weatherall Institute of Molecular Medicine · GBUniversity of Brescia · IT

Funding

CORE--ZEBRAFISHP30DK049216 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1999 to 2015
$14.3M
MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
Visualizing Effects of Costimulation on Antiviral ImmunityP01AI078897 · NIAID · HARVARD MEDICAL SCHOOL · PI SHARPE, ARLENE H. · 2008 to 2012
$12.1M
The Child Heath Research CenterK12HD052896 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Wendy K Chung · 2007 to 2026
$7.9M
T Cell Activation in Lymph NodesR01AI069259 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2006 to 2015
$4.5M
LRRC8 Signaling in T CellsR21AI079769 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI GEHA, RAIF SALIM, KUMAR, LALIT · 2008 to 2009
$466k
TEL GENE AND LEUKEMIASP50DK049216 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1994 to 1998
–
NIAID NIH HHS AI-069259NIAID NIH HHS AI-078897NIAID NIH HHS AI-183503NIAID NIH HHS AI-79769NIAID NIH HHS P01 AI078897NIAID NIH HHS R01 AI069259NIAID NIH HHS R21 AI079769NIAID NIH HHS T32 AI-007512NIAID NIH HHS T32 AI007512NICHD NIH HHS K12 HD052896NIDDK NIH HHS DK49216NIDDK NIH HHS P30 DK049216
6 · The paper itself

Abstract

Lrrc8a is a ubiquitously expressed gene that encodes a leucine-rich repeat (LRR)-containing protein detected at higher levels on the surface of thymocytes than on other immune cells. We generated Lrrc8a(-/-) mice to investigate the role of LRRC8A in lymphocyte development and function. Lrrc8a(-/-) mice had increased prenatal and postnatal mortality, growth retardation, and multiple tissue abnormalities. Lrrc8a(-/-) mice displayed a modest block in B cell development but intact intrinsic B cell function. In contrast, both Lrrc8a(-/-) mice and Lrrc8a(-/-)→Rag2(-/-) bone marrow chimeras exhibited a severe cell-intrinsic block in early thymic development, with decreased proliferation and increased apoptosis of thymocytes, and impaired peripheral T cell function. Thymic epithelial cells expressed an LRRC8A ligand that was critical for double-negative to double-positive thymocyte differentiation and survival in vitro. LRRC8A constitutively associated with the GRB2-GAB2 complex and lymphocyte-specific protein tyrosine kinase (LCK) in thymocytes. LRRC8A ligation activated AKT via the LCK-ZAP-70-GAB2-PI3K pathway, and AKT phosphorylation was markedly reduced in the thymus of Lrrc8a(-/-) mice. These findings reveal an essential role for LRRC8A in T cell development, survival, and function.

Indexed as

Analysis of VarianceAnimalsAntibodies, MonoclonalCell DifferentiationDNA-Binding ProteinsFlow CytometryImmunoblottingImmunohistochemistryMembrane ProteinsMiceMice, KnockoutMicroscopy, FluorescencePhosphorylationProto-Oncogene Proteins c-aktReal-Time Polymerase Chain ReactionThymocytesAntibodies, MonoclonalDNA-Binding ProteinsLRRC8A protein, mouseMembrane ProteinsProto-Oncogene Proteins c-aktRag2 protein, mouse

Identifiers

PMID24752297
PMCPMC4010910
OpenAlexW2111023308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.